[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 35.171.146.16. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
October 1972

Chlorpromazine in Chronic Schizophrenia: The Effect of Age and Hospitalization on Behavioral Dose-Response Relationships

Author Affiliations

Oklahoma City
From the Division of Clinical Pharmacology, Department of Medicine, University of Oklahoma Health Sciences Center, Oklahoma City, and Central State Griffin Memorial Hospital, Norman, Okla (Dr. Clark); the Department of Psychiatry and Behavioral Sciences, University of Oklahoma Health Sciences Center, Oklahoma City (Dr. Serafetinides): and the Division of Clinical Pharmacology, Department of Medicine, University of Oklahoma Health Sciences Center (Drs. Ramsey, Rahhal, Wood, and Costiloe).

Arch Gen Psychiatry. 1972;27(4):479-483. doi:10.1001/archpsyc.1972.01750280047009
Abstract

Behavioral data from a previous study were stratified by age (< 40 or > 40 years) and duration of hospitalization (< 10 or > 10 years) and examined for dose-response relationships at the 12th week of treatment with either placebo or 150, 300, or 600 mg chlorpromazine per day.

It was found that the shorter hospitalized patients (< 10 years) and to a lesser extent, the younger patients (< 40 years) as well, responded better to the higher dose (600 mg/day) whereas the longer hospitalized patients (> 10 years) and older patients ( ≥ 40 years) achieved no improvement in response beyond 300 mg/day.

×